Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-03-15
2005-03-15
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S286100, C435S287200, C435S288700, C436S164000, C436S172000
Reexamination Certificate
active
06867005
ABSTRACT:
This invention relates to methods for increasing the dynamic range and accuracy of assays in which the presence, absence, activity or concentration of a target analyte is assayed by the emission or quenching of a light signal, or by a change (i.e., an evolution or loss) of a light signal in two or more time intervals. In preferred embodiments multiple digitized images are captured at varying times, and the images analyzed to identify captured images within the dynamic range of the assay. The invention further relates to apparati capable of implementing such methods.
REFERENCES:
patent: 3791932 (1974-02-01), Schuurs et al.
patent: 4016043 (1977-04-01), Schuurs et al.
patent: 4185084 (1980-01-01), Mochida et al.
patent: 4243749 (1981-01-01), Sadeh et al.
patent: 4313734 (1982-02-01), Leuvering
patent: 4373932 (1983-02-01), Gribnau et al.
patent: 4401764 (1983-08-01), Smith
patent: 4661444 (1987-04-01), Li
patent: 4746631 (1988-05-01), Clagett
patent: 4810096 (1989-03-01), Russell et al.
patent: 4946958 (1990-08-01), Campbell et al.
patent: 5198670 (1993-03-01), VanCauter et al.
patent: 5306468 (1994-04-01), Anderson et al.
patent: 5501985 (1996-03-01), Baugher et al.
patent: 5563036 (1996-10-01), Peterson et al.
patent: 5599668 (1997-02-01), Stimpson et al.
patent: 5627080 (1997-05-01), Cheng et al.
patent: 5633141 (1997-05-01), Lee et al.
patent: 5679525 (1997-10-01), Peterson et al.
patent: 5691147 (1997-11-01), Draetta et al.
patent: 5698411 (1997-12-01), Lucas et al.
patent: 5747352 (1998-05-01), Yan et al.
patent: 5754229 (1998-05-01), Elabd
patent: 5772926 (1998-06-01), Akhavan-Tafti
patent: 5776782 (1998-07-01), Tsuji
patent: 5811526 (1998-09-01), Davidson
patent: 5843651 (1998-12-01), Stimpson et al.
patent: 5851778 (1998-12-01), Oh et al.
patent: 5876935 (1999-03-01), Pankratz et al.
patent: 5939281 (1999-08-01), Lehmann et al.
patent: 5965736 (1999-10-01), Akhavan-Tafti
patent: 5976822 (1999-11-01), Landrum et al.
patent: 6045727 (2000-04-01), Akhavan-Tafti et al.
patent: 6045991 (2000-04-01), Akhavan-Tafti
patent: 6057163 (2000-05-01), McMillan et al.
patent: 6090571 (2000-07-01), Akhavan-Tafti et al.
patent: 6139782 (2000-10-01), Akhavan-Tafti et al.
patent: 6177958 (2001-01-01), Anderson
patent: 6212291 (2001-04-01), Wang et al.
patent: 6218137 (2001-04-01), Akhavan-Tafti et al.
patent: 6270695 (2001-08-01), Akhavan-Tafti et al.
patent: 6287871 (2001-09-01), Herron et al.
patent: 6312960 (2001-11-01), Balch et al.
patent: 6337472 (2002-01-01), Garner et al.
patent: 6518068 (2003-02-01), Gambini et al.
patent: 177191 (1990-11-01), None
patent: 2084317 (1982-04-01), None
Bass, D.A. et al. “Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.”J. Immunol. 130: 1910-1917.
Bode, W. et al. 1989, “Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity and mechanism-based inhibitors,”Biochem. 28:1951-1963.
Coates, P.M. et al., 1975, “A preliminary genetic interpretation of the esterase isozymes of human tissues,”Ann. Hum. Genet. Lond. 39: 1-20.
Crockard, A. et al., 1982, “Cytochemistry of acid hydrolases in chronic B- and T-cell leukemias,”Am. J. Clin. Pathol. 78:437-444.
Dujardin, F.H., et al., “Quantitative assessment of cortical bone remodelling from routine radiographs of total hip arthroplasty,”Med. Eng. Phys. Sep. 1996; 18(6):489-94.
Ferrer-Lopez, P. et al., “Heparin Inhibits Neutrophil-Induced Platelet Activation Via Cathepsin”,J. Lab Clin. Med. 119(3), 231-239 (1992).
Fleischer, B., 1994, “CD26: a surface protease involved in T-cell activation,”Immunol. Today15: 180-184.
Fowler, A., et al., “A multi-modality assay platform for ultra-high throughput screening,”Curr. Pharm. Biotechnol. Nov. 2000;1(3):265-81.
Gartner, T.K. et al., 1985, “The tetrapeptide analogue of the alpha chain and decapeptide analogue of the gamma chain of fibrinogen bind to different sites on the platelet fibrinogen receptor,”Blood66 Suppl 1: 305a.
Hegen, M. et al., 1993, “Enzymatic activity of CD26 (dipeptidylpeptidase IV) is not required for its signalling function in T cells,”Immunobiology189: 483-493.
Hoffmann, T. et al. 1993, “Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences,”FEBS Letters336: 61-64.
Hohn, P.A. et al., 1989, “Genomic organization and chromosomal localization of the human cathepsin G gene,”J. Biol. Chem. 264: 13412-13419.
Houze T.A., et al., “Detection of thymidylate synthase gene expression levels in formalin-fixed paraffin embedded tissue by semiquantitative, nonradioactive reverse transcriptase polymerase chain reaction,”Tumour Biol. 1997;18(1):53-68.
Jongkind, J.F. et al., 1986, “Detection of acid-b-galactosidase activity in viable human fibroblasts by flow cytometry,”Cytometry7:463-466.
Kankaanranta, H. et al., 1994, “ Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates,”Naunyn-Schmiedeberg's Arch Pharmacol. 350:685-691.
Kohen, E. et al., 1993, “An in situ study of beta-glucosidase activity in normal and gaucher fibroblasts with fluorogenic probes,”Cell Biochem. and Function11:167-177.
Kojima, K. et al., 1979, “A new and highly sensitive fluorescence assay for collagenase-like peptidase activity,”Anal. Biochem. 100:43-50.
Li, C.Y. et al., 1970, “Acid phosphatase isoenzyme in human leukocytes in normal and pathologic conditions,”J. Histochem. Cytochem. 18:473-481.
Manzella S.M., et al. “A biphasic radiometric assay of glycogenin using the hydrophobic acceptor n-dodecyl-beta-D-maltoside,”Anal. Biochem. Feb. 1, 1994;216(2):383-91.
McDonald, J.A. et al., 1980, “Degradation of fibronectin by human leukocyte elastase,”J. Biol. Chem. 255: 8848-8858.
Mentlein, R. et al., H. R., “Influence of Pregnancy on Dipeptidyl Peptidase IV Activity (CD26 Leukocyte Differentiation Antigen) of Circulating Lymphocytes”,Eur. J. Clin. Chem. Clin. Biochem., 29, 477-480 (1991).
Messler P., et al., “Instrumentation for multiwavelengths excitation imaging,”J. Neurosci. MethodsNov. 1996;69(2):137-47).
Rotman, B. et al., 1963, “Fluorogenic substrates for b-D-galactosidases and phosphatases derived from fluorescein (3,6-dihydroxyfluoran) and its monomethyl ether,”Proc. Nat. Acad. Sci. USA50:1-6.
Royer, G., et al., “Immobilized Derivatives of Leucine Aminopeptidase and Aminopeptidase M.,”J. Biol. Chem. 248(5), 1807-1812 (1973).
Ruiz, P. et al., 1996, “Cytofluorographic evidence thatthymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny and apoptotic status,”Cytometry23: 322-329.
Sanderink, G.J., et al., 1988, Human Aminopeptidases: A Review of the Literature.J. Clin. Chem. Clin. Biochem. 26: 795-807.
Schon, E. et al., “The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro,”Eur. J. Immunol. Dec. 1987;17(12):1821-6.
Stein, R.L. et al. 1987, “Catalysis by human leukocyte elastase: Mechanistic insights into specificity requirements,”Biochem. 26:1301-1305.
Stein, R.L. et al. 1987, “Catalysis by human leukocyte elastase: Proton inventory as a mechanistic probe,”Biochem. 26:1305-1314.
Tanaka, T. et al., 1993, “The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity,”Proc. Natl. Acad. Sci. USA90:4586-4590.
Thiele, D.L. et al., 1990, “Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: Dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells,”
Keys Daniel A.
Reddy Parameswara M.
Beckman Coulter Inc.
Counts Gary W.
Hill D. David
Le Long V.
Liniak, Berenato & White, LLC
LandOfFree
Method and apparatus for increasing the dynamic range and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and apparatus for increasing the dynamic range and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and apparatus for increasing the dynamic range and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3437094